2
|
Giussani A, Lopez MA, Romm H, Testa A, Ainsbury EA, Degteva M, Della Monaca S, Etherington G, Fattibene P, Güclu I, Jaworska A, Lloyd DC, Malátová I, McComish S, Melo D, Osko J, Rojo A, Roch-Lefevre S, Roy L, Shishkina E, Sotnik N, Tolmachev SY, Wieser A, Woda C, Youngman M. Eurados review of retrospective dosimetry techniques for internal exposures to ionising radiation and their applications. RADIATION AND ENVIRONMENTAL BIOPHYSICS 2020; 59:357-387. [PMID: 32372284 PMCID: PMC7369133 DOI: 10.1007/s00411-020-00845-y] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/08/2019] [Accepted: 04/15/2020] [Indexed: 05/17/2023]
Abstract
This work presents an overview of the applications of retrospective dosimetry techniques in case of incorporation of radionuclides. The fact that internal exposures are characterized by a spatially inhomogeneous irradiation of the body, which is potentially prolonged over large periods and variable over time, is particularly problematic for biological and electron paramagnetic resonance (EPR) dosimetry methods when compared with external exposures. The paper gives initially specific information about internal dosimetry methods, the most common cytogenetic techniques used in biological dosimetry and EPR dosimetry applied to tooth enamel. Based on real-case scenarios, dose estimates obtained from bioassay data as well as with biological and/or EPR dosimetry are compared and critically discussed. In most of the scenarios presented, concomitant external exposures were responsible for the greater portion of the received dose. As no assay is available which can discriminate between radiation of different types and different LETs on the basis of the type of damage induced, it is not possible to infer from these studies specific conclusions valid for incorporated radionuclides alone. The biological dosimetry assays and EPR techniques proved to be most applicable in cases when the radionuclides are almost homogeneously distributed in the body. No compelling evidence was obtained in other cases of extremely inhomogeneous distribution. Retrospective dosimetry needs to be optimized and further developed in order to be able to deal with real exposure cases, where a mixture of both external and internal exposures will be encountered most of the times.
Collapse
Affiliation(s)
- A Giussani
- BfS-Bundesamt für Strahlenschutz, Ingolstädter Landstr. 1, 85764, Oberschleißheim, Germany.
| | - M A Lopez
- CIEMAT - Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Av.da Complutense 40, 28040, Madrid, Spain
| | - H Romm
- BfS-Bundesamt für Strahlenschutz, Ingolstädter Landstr. 1, 85764, Oberschleißheim, Germany
| | - A Testa
- ENEA Casaccia Research Center, Via Anguillarese 301, Santa Maria di Galeria, 00123, Rome, Italy
| | - E A Ainsbury
- Public Health England - Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, OX11 0RQ, Oxon, UK
| | - M Degteva
- Urals Research Center for Radiation Medicine (URCRM), Vorovskt str. 68A, Chelyabinsk, 454141, Russia
| | - S Della Monaca
- Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy
| | - G Etherington
- Public Health England - Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, OX11 0RQ, Oxon, UK
| | - P Fattibene
- Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy
| | - I Güclu
- Cekmece Nuclear Research and Training Center Radiobiology Unit Yarımburgaz, Turkish Atomic Energy Authority, Istanbul, Turkey
| | - A Jaworska
- DSA-Norwegian Radiation and Nuclear Safety Authority, Skøyen, P. O. Box 329, 0213, Oslo, Norway
| | - D C Lloyd
- Public Health England - Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, OX11 0RQ, Oxon, UK
| | - I Malátová
- SURO-National Radiation Protection Institute, Bartoskova 28, 14000, Prague, Czech Republic
| | - S McComish
- US Transuranium and Uranium Registries, Washington State University, Richland, WA, USA
| | - D Melo
- Melohill Technology, 1 Research Court, Rockville, MD, 20850, USA
| | - J Osko
- National Centre for Nuclear Research, A. Soltana 7, 05400, Otwock, Poland
| | - A Rojo
- ARN-Nuclear Regulatory Authority of Argentina, Av. del Libertador 8250, Buenos Aires, Argentina
| | - S Roch-Lefevre
- Institut de Radioprotection et de Sûreté Nucléaire, IRSN, Pôle Santé et Environnement, Direction de la Santé, Fontenay-aux-Roses, France
| | - L Roy
- Institut de Radioprotection et de Sûreté Nucléaire, IRSN, Pôle Santé et Environnement, Direction de la Santé, Fontenay-aux-Roses, France
| | - E Shishkina
- Urals Research Center for Radiation Medicine (URCRM), Vorovskt str. 68A, Chelyabinsk, 454141, Russia
- Chelyabinsk State University (ChelSU), 129, Bratiev Kashirinih Street, Chelyabinsk, 454001, Russia
| | - N Sotnik
- Southern Urals Biophysics Institute (SUBI), Ozyorsk, Chelyabinsk Region, 456780, Russia
| | - S Y Tolmachev
- US Transuranium and Uranium Registries, Washington State University, Richland, WA, USA
| | - A Wieser
- Institute of Radiation Medicine, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany
| | - C Woda
- Institute of Radiation Medicine, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany
| | - M Youngman
- Public Health England - Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, OX11 0RQ, Oxon, UK
| |
Collapse
|
3
|
Khvostunov IK, Saenko VA, Krylov V, Rodichev A, Yamashita S. Cytogenetic biodosimetry and dose-rate effect after radioiodine therapy for thyroid cancer. RADIATION AND ENVIRONMENTAL BIOPHYSICS 2017; 56:213-226. [PMID: 28526978 DOI: 10.1007/s00411-017-0696-3] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/23/2016] [Accepted: 05/11/2017] [Indexed: 06/07/2023]
Abstract
This study set out to investigate chromosomal damage in peripheral blood lymphocytes of thyroid cancer patients receiving 131I for thyroid remnant ablation or treatment of metastatic disease. The observed chromosomal damage was further converted to the estimates of whole-body dose to project the adverse side effects. Chromosomal aberration analysis was performed in 24 patients treated for the first time or after multiple courses. Blood samples were collected before treatment and 3 or 4 days after administration of 2-4 GBq of 131I. Both conventional cytogenetic and chromosome 2, 4 and 12 painting assays were used. To account for dose-rate effect, a dose-protraction factor was applied to calculate the whole-body dose. The mean dose was 0.62 Gy (95% CI: 0.44-0.77 Gy) in the subgroup of patients treated one time and 0.67 Gy (95% CI: 0.03-1.00 Gy) in re-treated patients. These dose estimates are about 1.7-fold higher than those disregarding the effect of exposure duration. In re-treated patients, the neglected dose-rate effect can result in underestimation of the cumulative whole-body dose by the factor ranging from 2.6 to 6.8. Elevated frequency of chromosomal aberrations observed in re-treated patients before radioiodine therapy allows estimation of a cumulative dose received from all previous treatments.
Collapse
Affiliation(s)
- Igor K Khvostunov
- A.F. Tsyb Medical Radiological Research Center, Branch of the National Medical Research Radiological Centre, Russian Ministry of Health Care, Koroliova str. 4, Obninsk, Kaluga Region, Russia, 249036.
- Department of Radiation Molecular Epidemiology, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, Japan.
| | - Vladimir A Saenko
- Department of Radiation Molecular Epidemiology, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, Japan
| | - Valeri Krylov
- A.F. Tsyb Medical Radiological Research Center, Branch of the National Medical Research Radiological Centre, Russian Ministry of Health Care, Koroliova str. 4, Obninsk, Kaluga Region, Russia, 249036
| | - Andrei Rodichev
- A.F. Tsyb Medical Radiological Research Center, Branch of the National Medical Research Radiological Centre, Russian Ministry of Health Care, Koroliova str. 4, Obninsk, Kaluga Region, Russia, 249036
| | - Shunichi Yamashita
- Department of Radiation Molecular Epidemiology, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, Japan
| |
Collapse
|
4
|
Kaddour A, Colicchio B, Buron D, El Maalouf E, Laplagne E, Borie C, Ricoul M, Lenain A, Hempel WM, Morat L, Al Jawhari M, Cuceu C, Heidingsfelder L, Jeandidier E, Deschênes G, Dieterlen A, El May M, Girinsky T, Bennaceur-Griscelli A, Carde P, Sabatier L, M'kacher R. Transmission of Induced Chromosomal Aberrations through Successive Mitotic Divisions in Human Lymphocytes after In Vitro and In Vivo Radiation. Sci Rep 2017; 7:3291. [PMID: 28607452 PMCID: PMC5468351 DOI: 10.1038/s41598-017-03198-7] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2017] [Accepted: 04/24/2017] [Indexed: 11/10/2022] Open
Abstract
The mechanisms behind the transmission of chromosomal aberrations (CA) remain unclear, despite a large body of work and major technological advances in chromosome identification. We reevaluated the transmission of CA to second- and third-division cells by telomere and centromere (TC) staining followed by M-FISH. We scored CA in lymphocytes of healthy donors after in vitro irradiation and those of cancer patients treated by radiation therapy more than 12 years before. Our data demonstrate, for the first time, that dicentric chromosomes (DCs) decreased by approximately 50% per division. DCs with two centromeres in close proximity were more efficiently transmitted, representing 70% of persistent DCs in ≥M3 cells. Only 1/3 of acentric chromosomes (ACs), ACs with four telomeres, and interstitial ACs, were paired in M2 cells and associated with specific DCs configurations. In lymphocytes of cancer patients, 82% of detected DCs were characterized by these specific configurations. Our findings demonstrate the high stability of DCs with two centromeres in close proximity during cell division. The frequency of telomere deletion increased during cell cycle progression playing an important role in chromosomal instability. These findings could be exploited in the follow-up of exposed populations.
Collapse
Affiliation(s)
- Akram Kaddour
- Laboratory of Radiobiology and Oncology and PROCyTOX, DRF, CEA, Paris-Saclay, France.,Tunis El Manar University, School of Medicine, Tunis, Tunisia
| | - Bruno Colicchio
- Laboratoire MIPS Groupe IMTI Université de Haute-Alsace, Mulhouse, France
| | - Diane Buron
- Laboratory of Radiobiology and Oncology and PROCyTOX, DRF, CEA, Paris-Saclay, France
| | - Elie El Maalouf
- Laboratoire MIPS Groupe IMTI Université de Haute-Alsace, Mulhouse, France
| | | | - Claire Borie
- APHP-Hopital Paul Brousse Université Paris Sud/ESteam Paris Inserm UMR 935, Villejuif, France
| | - Michelle Ricoul
- Laboratory of Radiobiology and Oncology and PROCyTOX, DRF, CEA, Paris-Saclay, France
| | - Aude Lenain
- Laboratory of Radiobiology and Oncology and PROCyTOX, DRF, CEA, Paris-Saclay, France
| | - William M Hempel
- Laboratory of Radiobiology and Oncology and PROCyTOX, DRF, CEA, Paris-Saclay, France
| | - Luc Morat
- Laboratory of Radiobiology and Oncology and PROCyTOX, DRF, CEA, Paris-Saclay, France
| | - Mustafa Al Jawhari
- Laboratory of Radiobiology and Oncology and PROCyTOX, DRF, CEA, Paris-Saclay, France
| | - Corina Cuceu
- Laboratory of Radiobiology and Oncology and PROCyTOX, DRF, CEA, Paris-Saclay, France
| | | | - Eric Jeandidier
- Service de Génétique Groupe Hospitalier de la Région de Mulhouse et Sud Alsace, 68070, Mulhouse, France
| | | | - Alain Dieterlen
- Laboratoire MIPS Groupe IMTI Université de Haute-Alsace, Mulhouse, France
| | - Michèle El May
- Tunis El Manar University, School of Medicine, Tunis, Tunisia
| | - Theodore Girinsky
- Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France
| | | | - Patrice Carde
- Department of Hematology, Gustave Roussy cancer Campus, Villejuif, France
| | - Laure Sabatier
- Laboratory of Radiobiology and Oncology and PROCyTOX, DRF, CEA, Paris-Saclay, France
| | - Radhia M'kacher
- Laboratory of Radiobiology and Oncology and PROCyTOX, DRF, CEA, Paris-Saclay, France. .,Cell Environment, Paris, France.
| |
Collapse
|